JNJ-42226314

• Description:

  JNJ-42226314 is a highly selective non-covalent monoacylglycerol lipase (MAGL) inhibitor with anti-injury effects.JNJ-42226314 shows efficacy via endogenous cannabinoid-2-acryloylglycerol (2-AG) in models of neuropathic pain and inflammatory pain.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  489.56

• Molecular Formula:

  C26H24FN5O2S

• Notes:

  Research use only, not for human use.

• Receptor:

  Lipase

• CAS Number:

  1252765-13-1